Trials / Withdrawn
WithdrawnNCT01749423
A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the effectiveness of OnabotulinumtoxinA to prevent headaches in patients with Chronic Migraine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | OnabotulinumtoxinA | Previous treatment with onabotulinumtoxinA for Chronic Migraine. |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2012-12-13
- Last updated
- 2014-02-03
Source: ClinicalTrials.gov record NCT01749423. Inclusion in this directory is not an endorsement.